We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Noninvasive Test for Endometriosis Developed

By LabMedica International staff writers
Posted on 07 Dec 2014
Image: Photomicrograph of endometriosis of the ovary (Photo courtesy of Nephron).
Image: Photomicrograph of endometriosis of the ovary (Photo courtesy of Nephron).
Endometriosis is diagnosed and staged at surgery, resulting in an 11-year latency from symptom onset to diagnosis, underscoring the need for less invasive, less expensive approaches.

Patterns of genetic activity have been identified that can be used to diagnose endometriosis and its severity, a finding that may offer millions of women an alternative to surgery through a simple noninvasive procedure.

Scientists at the University of California San Francisco (CA, USA) identified 148 archived endometrial samples from different menstrual cycle phases from 77 women with endometriosis and pelvic pain and/or infertility; 37 with no endometriosis but with uterine/pelvic pathology (NE.UPP) including symptomatic uterine fibroids, pelvic organ prolapse, and adenomyosis; and 34 with no endometriosis and no uterine/pelvic pathology (NE.NUPP), classified as normal controls.

Whole-tissue samples were processed using rigorous protocols and hybridized to whole-genome microarrays. Total ribonucleic acid (RNA) was purified from specimens, and only high-quality RNA samples were processed for hybridization to Human Genome 133 Plus 2.0 high-density oligonucleotide arrays (Affymetrix; Santa Clara, CA, USA). Menstrual cycle phase was assigned by endometrial histology reviewed by two pathologists, and confirmed by serum estradiol and P4 levels.

The team used machine learning, a computer-based technology, to analyze the gene activity of the endometrium tissue samples. With an accuracy of 90% to 100 %, a grouping system from the samples was developed. Not only could the investigators distinguish between samples from endometriosis patients and the control group but also between the endometriosis patients and those patients with other uterine disorders. They even could denote the difference between endometriosis stages.

This technique also could distinguish endometriosis at different points in the menstrual cycle. As hormone levels changed throughout the cycle, the gene expression patterns in the uterine lining of women with endometriosis were distinct from those who did not have the condition.

Based on this gene expression, a simple test eventually could be performed in the doctor's office to determine endometriosis and stage. In just minutes, a tiny, thin plastic catheter could be inserted through the cervix into the uterus to remove a sample of cells for analysis.

Louis V. DePaolo, PhD, a contributing author of the study said, “Laparoscopy involves general anesthesia and making an incision in the abdomen. These findings indicate that it may be possible to avoid the surgical procedure and diagnose endometriosis from a tissue sample obtained in the office setting without anesthesia.” The study was published on September 22, 2014, in the journal Endocrinology.

Related Links:

University of California San Francisco 
Affymetrix



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Rapid Molecular Testing Device
FlashDetect Flash10

Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more